Cramer’s lightning round: I like Truist

Cramer’s lightning round: I like Truist


PPG Industries Inc: “I think PPG is down too much. I think it’s okay, but … This is a company that has been really hurt by raw costs. That’s going to end eventually. I think if you can handle disappointment at this point, I would buy the stock.”

AppFolio Inc: “You’ve got a software portfolio that is meant for housing. And I think it’s much needed, and it reminds me very much of Anaplan, which got a bid today from Thoma Bravo.”

Berkshire Hathaway Inc Class B: ” I think [having it as more than a third of a portfolio is] a lot for any one particular company, but I do love the company so much. Let’s cut it to 20% [of a portfolio], so that we can sleep better at night.”

Star Bulk Carriers Corp: “I think the dividend’s too high, but for what’s going on right now in Ukraine, I think it’s actually going to be good for the next year.”

Vaalco Energy Inc: “This is, yes. It will work. It will work because [the price of] oil is so high, even though I don’t like their business model.”

Truist Financial Corp: “I like Truist. … They’re in the right place where wealth is, they’re a very smart-run bank, I think it’s a good place to be.”



Source

Historic winter storms weigh on Gap, Old Navy performance after 800 temporary store closures
Business

Historic winter storms weigh on Gap, Old Navy performance after 800 temporary store closures

Pedestrians in the snow at Times Square during a winter storm in New York, US, on Sunday, Feb. 22, 2026. Bloomberg | Bloomberg | Getty Images Historic winter storms and subsequent store closures weighed on Gap’s performance during its holiday quarter and contributed to worse-than-expected results at its portfolio of brands, the retailer said Thursday.  […]

Read More
FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease
Business

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease

Thomas Fuller | SOPA Images | Lightrocket | Getty Images UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday. The official, who requested anonymity before discussing sensitive information, confirmed the agency […]

Read More
Home sellers are relisting properties at fastest pace in a decade, but spring supply is still low
Business

Home sellers are relisting properties at fastest pace in a decade, but spring supply is still low

A “For Sale” sign outside a house in the Capitol Hill neighborhood of Washington, DC, US, on Tuesday, Aug. 12, 2025. Al Drago | Bloomberg | Getty Images The all-important spring housing market is off and running, and while the pace isn’t expected to be strong, there are signs of optimism, at least among sellers. […]

Read More